Prognose
Analytikernes gennemsnitlige kursmål er 117,34 € (+4,77 %). Medianen er 123,49 € (+10,26 %).
| Køb |
15 |
| Behold |
2 |
| Sælg |
1 |
Diskussioner i communityet
Der er endnu ingen diskussion om dette aktiv.
Start diskussionNyheder Til nyhedsfeedet
Addus HomeCare announces acquisition of AccentCare personal-care unit and growth plan
Addus HomeCare will acquire AccentCare’s personal care services unit for $275 million; the deal has a revenue run rate of $280 million and is expected to close in Q1 2027. Management views the acquisition as a key growth step, expects gradual margin improvements in the AccentCare business within 12–18 months, and plans phased system integrations through end‑2027/early 2028. Consolidated personal-care utilization improves company‑wide (84–85%), and Addus targets same‑store revenue growth of 3–5%; after closing the company expects a pro‑forma leverage ratio just above 1.0x and remains open to further acquisitions. » Mere på de.investing.com
Addus HomeCare says license moratorium won't hinder personal care growth or M&A plans
Addus HomeCare said the federal moratorium on certain home health licenses does not apply to personal care services (PCS), which have driven its recent acquisitions, and therefore should not slow revenue growth. Management reported improving PCS census trends and higher caregiver fill rates after deploying a caregiver app in key states like Illinois and Texas. The company highlighted acquisition opportunities—including expansion in Indiana—saying deal valuations have declined and its balance sheet and credit line allow rapid execution. Addus also continues clinical and hospice integrations while converting PCS to a unified EMR to better identify referrals and care transitions. » Mere på finance.yahoo.com
Addus HomeCare falls to 52-week low at $90.80
Shares of Addus HomeCare hit a 52-week low of $90.80 and have fallen about 16% over the past year. Key metrics: P/E 17, PEG 0.78 and a market capitalization of roughly $1.68 billion, suggesting potential undervaluation. The company reported Q1 2026 EPS of $1.62 (expected $1.55) on revenue of $363.6 million, which missed the consensus but rose 7.7% year over year. In response to the revenue miss, a financial services firm cut its price target from $150 to $142 and kept its rating at "Market Outperform." » Mere på de.investing.com
Addus reports Q1 2026 revenue up 7.7% and strengthens cash flow while expanding into Indiana
Addus delivered Q1 2026 revenue of $363.6 million, a 7.7% increase year-over-year, with adjusted EPS of $1.62 and adjusted EBITDA of $44.5 million. Operating cash flow rose to $52.4 million, cash on hand was about $103 million and bank debt fell to $94.3 million, giving the company capacity for M&A. The firm closed the HomeCourt Home Care personal care acquisition in Indiana and signed a second Indiana deal pending approvals, continuing a strategy to add scale and geographic density. Personal care same-store revenue rose 6.5% and hospice same-store revenue rose 7.7%, while Addus emphasized caregiver-app rollouts to boost hours served and operational efficiency. » Mere på finance.yahoo.com
Addus HomeCare shares fall to 52-week low at $91.10
Addus HomeCare shares hit a 52-week low of $91.10 and are down 5.58% year to date. Key metrics show a P/E ratio of 17.56 and a PEG of 0.74; InvestingPro rates the stock as undervalued and the RSI signals oversold conditions. The company remains profitable with revenue growth of 23% over the past twelve months. Several analysts reiterated buy or overweight ratings with price targets between $135 and $150, though a few analysts slightly lowered their targets. » Mere på de.investing.com
Virksomhedstal
I det seneste kvartal havde Addus HomeCare en omsætning på 342,31 mio. € og et nettoresultat på 25,24 mio. €
| (EUR) | september 2026 | YoY |
|---|---|---|
| Omsætning | 342,31 mio. | 10,88 % |
| Bruttofortjeneste | 109,82 mio. | 10,43 % |
| Nettoresultat | 25,24 mio. | 29,66 % |
| EBITDA | 38,81 mio. | 19,51 % |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 2,05 mia. € |
Antal aktier | 18,63 mio. |
Højeste/laveste i 52 uger | 119,92 € - 80,15 € |
| Udbytte | Nej |
Beta | 0,75 |
P/E (PE Ratio) | 20,14 |
PEG (PEG Ratio) | 0,73 |
K/I (PB Ratio) | 1,90 |
P/S (PS Ratio) | 1,50 |
Virksomhedsprofil
Addus HomeCare Corporation yder sammen med sine datterselskaber personlig pleje til ældre, kronisk syge, handicappede personer og personer, der er i risiko for indlæggelse eller institutionsanbringelse i USA. Virksomheden er organiseret i tre segmenter: Personal Care, Hospice og Home Health. Segmentet Personal Care leverer ikke-medicinsk hjælp til dagligdags aktiviteter. Segmentet tilbyder ydelser, herunder hjælp til badning, personlig pleje, mundpleje, madning og påklædning, medicinpåmindelser, måltidsplanlægning og tilberedning, husholdning og transportydelser. Segmentet Hospice leverer palliativ sygepleje, socialt arbejde, åndelig rådgivning, hjemmehjælp og sorgrådgivning til personer, der er uhelbredeligt syge, samt tilhørende ydelser til deres familier. Segmentet Home Health tilbyder kvalificeret sygepleje samt fysio-, ergo- og talterapi til personer, der har brug for hjælp under sygdom eller efter indlæggelse. Virksomhedens betalere omfatter føderale, statslige og lokale offentlige myndigheder, managed care-organisationer, kommercielle forsikringsselskaber og private personer. Pr. 31. december 2021 betjente virksomheden forbrugere gennem 206 kontorer placeret i 22 delstater. Addus HomeCare Corporation blev grundlagt i 1979 og har hovedkontor i Frisco, Texas.
| Navn | Addus HomeCare |
| CEO | R. Dirk Allison |
| Hjemsted | Frisco,
tx USA |
| Websted | |
| Sektor | Sundhed |
| Branche | Sundhedsudbydere og -tjenester |
| Børsnotering | 28.10.2009 |
| Medarbejdere | 50.659 |
Tickersymboler
| Børs | Symbol |
|---|---|
NASDAQ | ADUS |
Frankfurt | A41.F |
Düsseldorf | A41.DU |
SIX | A41.SW |
München | A41.MU |